SCHEMBL14295342

SCHEMBL14295342

c1ccc(-n2c3ccccc3c3cc(N(c4ccc(-c5ccc(N(c6ccc7oc8ccccc8c7c6)c6cc7ccccc7c7ccccc67)cc5)cc4)c4cc5ccccc5c5ccccc45)ccc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ SIRT1 Q96EB6 1/20 0.35
▸ MAPT P10636 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PTGER4 P35408 1/20 0.31
▸ GLA P06280 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295335 1.00 KDM4E (0.37) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL14902057 0.98 KDM4E (0.35) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL12282556 0.96 KDM4E (0.37) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL14902074 0.95 TSPO (0.34) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL14295337 0.95 KDM4E (0.36) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL14295336 0.95 KDM4E (0.36) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL14902078 0.93 TSPO (0.35) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL18802475 0.92 KDM4E (0.35) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL17637202 0.92 KDM4E (0.35) KDM4EL3MBTL1ATMSIRT2SIRT1
SCHEMBL18327432 0.91 ATM (0.36) KDM4EL3MBTL1ATMSIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10276637-B2 Organic EL multi-color light-emitting device IDEMITSU KOSAN CO., LTD. (JP) 2019-04-30 — — US disclosed
US-20140159023-A1 ORGANIC EL MULTI-COLOR LIGHT-EMITTING DEVICE Idemitsu Co., Ltd. (JP) 2014-06-12 — — US disclosed
US-20140159023-A1 ORGANIC EL MULTI-COLOR LIGHT-EMITTING DEVICE Idemitsu Co., Ltd. (JP) 2014-06-12 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 KDM4E 463/4885L3MBTL1 864/4885ATM 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback